DK1952805T3 - Tablet indeholdende hydrogenerede phospholipider - Google Patents

Tablet indeholdende hydrogenerede phospholipider

Info

Publication number
DK1952805T3
DK1952805T3 DK08100830.2T DK08100830T DK1952805T3 DK 1952805 T3 DK1952805 T3 DK 1952805T3 DK 08100830 T DK08100830 T DK 08100830T DK 1952805 T3 DK1952805 T3 DK 1952805T3
Authority
DK
Denmark
Prior art keywords
tablet containing
containing hydrogenated
hydrogenated phospholipids
phospholipids
tablet
Prior art date
Application number
DK08100830.2T
Other languages
English (en)
Inventor
Ulrich Massing
Annette Bauer-Brandl
Original Assignee
Ktb Tumorforschungs Gmbh
Univ Tromsoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ktb Tumorforschungs Gmbh, Univ Tromsoe filed Critical Ktb Tumorforschungs Gmbh
Application granted granted Critical
Publication of DK1952805T3 publication Critical patent/DK1952805T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK08100830.2T 2007-01-23 2008-01-23 Tablet indeholdende hydrogenerede phospholipider DK1952805T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07101047A EP1952803A1 (en) 2007-01-23 2007-01-23 Solid pharmaceutical dosage form containing hydrogenated phospholipids

Publications (1)

Publication Number Publication Date
DK1952805T3 true DK1952805T3 (da) 2012-12-17

Family

ID=38066929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08100830.2T DK1952805T3 (da) 2007-01-23 2008-01-23 Tablet indeholdende hydrogenerede phospholipider

Country Status (4)

Country Link
US (1) US20080187583A1 (da)
EP (2) EP1952803A1 (da)
DK (1) DK1952805T3 (da)
SI (1) SI1952805T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3991722A4 (en) * 2019-06-28 2022-10-05 Jiangsu Hengrui Medicine Co., Ltd. LIPID COMPOSITION WITH DELAYED RELEASE AND THEIR PROCESS OF PRODUCTION

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2057695A (en) * 1933-12-13 1936-10-20 American Lecithin Co Method for the production of vegetable phosphatide preparations
JPS5457820A (en) 1977-10-17 1979-05-10 Ricoh Co Ltd Pre-processing system for coding of pattern information
US4374082A (en) 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4882167A (en) 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
JPS6348226A (ja) * 1986-08-14 1988-02-29 Ono Pharmaceut Co Ltd 徐放性を有する経口投与用固形製剤
US4762658A (en) 1986-10-08 1988-08-09 Central Soya Company, Inc. Method of tableting of de-oiled phosphatides (lecithin)
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
GB2305604B (en) 1995-09-29 1999-06-23 Quest Vitamins Ltd Carrier base material
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
CA2315088A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
AU1787800A (en) 1998-12-08 2000-06-26 Phares Pharmaceutical Research N.V. Phospholipid compositions
US20030161879A1 (en) 1999-06-29 2003-08-28 Shinji Ohmori Tablets quickly disintegrating in mouth
AU763041B2 (en) 1999-08-25 2003-07-10 Alkermes, Inc. Modulation of release from dry powder formulations
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
FR2814366A1 (fr) * 2000-09-22 2002-03-29 Rhodia Chimie Sa Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
EP1334718A4 (en) * 2000-10-26 2007-07-18 Senju Pharma Co DRUG COMPOSITION CONTAINING DIPEPTIDYL ALDEHYDE COMPOUND
EP1401402B1 (en) 2001-05-29 2016-09-07 Takeda Pharmaceuticals U.S.A., Inc. Enhancement of oral bioavailability of non-emulsified formulation of cefditoren pivoxil with lecithin
EP1543841A4 (en) 2002-08-15 2011-03-16 Yunqing Liu SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
DE10340741A1 (de) 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Formulierung auf Phospholipidbasis
CA2540984C (en) * 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
EP1745788A1 (de) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
JP5352466B2 (ja) * 2006-11-10 2013-11-27 アルファプトーゼ ゲーエムベーハー トリ置換グリセロール化合物を含む経口投与剤形、経口投与剤形の調製方法、経口投与剤形の使用方法

Also Published As

Publication number Publication date
US20080187583A1 (en) 2008-08-07
EP1952805A1 (en) 2008-08-06
EP1952803A1 (en) 2008-08-06
SI1952805T1 (sl) 2013-07-31
EP1952805B1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
DK3090730T3 (da) Tabletter omfattende eltrombopag-olamin
LTPA2018005I1 (lt) Farmacinė kompozicija
EP2054752A4 (en) AUTOSTEREOSCOPIC DISPLAY
DE602008003596D1 (de) Stereoskopische Anzeigevorrichtung
EP2119463A4 (en) MEDICAL CONTAINER
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
BRPI0920521A2 (pt) combinação farmacêutica
EP2251005A4 (en) Orally disintegrating tablets
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
DK2120884T3 (da) Farmaceutisk sammensætning
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0821735A2 (pt) Fabricação de tablete
DE502007005910D1 (de) Tablettenabfüllvorrichtung
PT2209464E (pt) Composição farmacêutica antimalárica
EP2197448A4 (en) dosing schedule
EP2016087A4 (en) HYDROGENATION PROCESS
BRPI0819359A2 (pt) Unidade de embalagem
EP2057985A4 (en) DRAGEE
DK1952805T3 (da) Tablet indeholdende hydrogenerede phospholipider
DE602007009636D1 (de) Sektionaltor
EP2050456A4 (en) COMPRESSED
BRPI0820839A2 (pt) Composição farmacêutica
FR2926088B1 (fr) Tablette detergente multicouche
FR2924587B1 (fr) Presentoir
FR2916433B1 (fr) Decoupe capsule